US 10835593
Modified anthrax toxin protective antigen
granted A61KA61K2039/5158A61K2039/55522
Quick answer
US patent 10835593 (Modified anthrax toxin protective antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/5158, A61K2039/55522, A61K39/07, A61K45/06